(Q41729344)

8 October 2017

Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial (English)

1 reference

8 October 2017

0 references

1 reference

1 reference

10

Tobias Welte

1 reference

8 October 2017

Diana Bilton

1

1 reference

8 October 2017

Gregory Tino

2

1 reference

8 October 2017

Alan F Barker

3

1 reference

8 October 2017

Daniel C Chambers

4

1 reference

8 October 2017

Anthony De Soyza

5

1 reference

8 October 2017

Lieven J A Dupont

6

1 reference

8 October 2017

Conor O'Dochartaigh

7

1 reference

8 October 2017

Eric H J van Haren

8

1 reference

8 October 2017

Luis Otero Vidal

9

1 reference

8 October 2017

Howard G Fox

11

1 reference

8 October 2017

Jian Wu

12

1 reference

8 October 2017

Brett Charlton

13

1 reference

8 October 2017

B-305 Study Investigators

14

1 reference

8 October 2017

language of work or name

English

0 references

publication date

21 September 2014

1 reference

8 October 2017

1 reference

8 October 2017

69

1 reference

8 October 2017

1073-1079

1 reference

8 October 2017

12

1 reference

Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century

8 October 2017

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

Bronchiectasis in Central Australia: a young face to an old disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

New Zealand national incidence of bronchiectasis "too high" for a developed country.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

Non-CF bronchiectasis: clinical and HRCT evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

British Thoracic Society guideline for non-CF bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

British Thoracic Society national bronchiectasis audit 2010 and 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2014-205587

10.1136/THORAXJNL-2014-205587

21 January 2018

Identifiers

DOI

1 reference

8 October 2017

1 reference